{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:18:00Z","timestamp":1793132280259,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03219-8","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T18:16:04Z","timestamp":1779732964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Shared pathophysiological mechanisms between diabetes and calcific aortic valve disease: an immunometabolic perspective"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhang","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuchen","family":"SiTu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-hui","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-xiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"3219_CR1","doi-asserted-by":"publisher","unstructured":"Pranay W, Shruti R, Namra A, Yash Kumar S, Arpit G. Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus. Egypt Heart J. 2023;75(1). https:\/\/doi.org\/10.1186\/s43044-023-00345-6.","DOI":"10.1186\/s43044-023-00345-6"},{"key":"3219_CR2","doi-asserted-by":"publisher","unstructured":"Feng L, Haipeng C. Diabetes and calcific aortic valve disease: implications of glucose-lowering medication as potential therapy. Front Pharmacol. 2025;16(0). https:\/\/doi.org\/10.3389\/fphar.2025.1583267.","DOI":"10.3389\/fphar.2025.1583267"},{"key":"3219_CR3","doi-asserted-by":"publisher","unstructured":"Hyun-Jung L, Chan Soon P, Sahmin L, Jun-Bean P, Hyung-Kwan K, Sung-Ji P, et al. Systemic proinflammatory-profibrotic response in aortic stenosis patients with diabetes and its relationship with myocardial remodeling and clinical outcome. Cardiovasc Diabetol. 2023;22(1). https:\/\/doi.org\/10.1186\/s12933-023-01763-1.","DOI":"10.1186\/s12933-023-01763-1"},{"key":"3219_CR4","doi-asserted-by":"publisher","unstructured":"Kangning H, Dongmei S, Lixia Y, Meng X, Rongrong Z, Zhijian W, et al. Diabetes Is Associated With Rapid Progression of Aortic Stenosis: A Single-Center Retrospective Cohort Study. Front Cardiovasc Med. 2022;8(0). https:\/\/doi.org\/10.3389\/fcvm.2021.812692.","DOI":"10.3389\/fcvm.2021.812692"},{"issue":"5","key":"3219_CR5","doi-asserted-by":"publisher","first-page":"147916412110338","DOI":"10.1177\/14791641211033819","volume":"18","author":"C Roderburg","year":"2021","unstructured":"Roderburg C, Loosen SH, Luedde T, Kostev K, Luedde M. Diabetes mellitus is associated with an increased incidence of aortic valve stenosis. Diab Vasc Dis Res. 2021;18(5):14791641211033819. https:\/\/doi.org\/10.1177\/14791641211033819.","journal-title":"Diab Vasc Dis Res"},{"key":"3219_CR6","doi-asserted-by":"publisher","unstructured":"Chaolei C, Zehan H, Lin L, Bingbing S, Yingqing F, Yuqing H. Hyperglycaemia and genetic susceptibility in relation to incident degenerative aortic valve stenosis. Eur J Prev Cardiol. 2025;32(17). https:\/\/doi.org\/10.1093\/eurjpc\/zwaf355.","DOI":"10.1093\/eurjpc\/zwaf355"},{"key":"3219_CR7","doi-asserted-by":"publisher","unstructured":"Viktor L, Pia L, Leif F, Mats T, Niklas H, G\u00f6ran W, et al. Dysglycaemia and incident aortic stenosis: a cohort study. Heart. 2025;111(14). https:\/\/doi.org\/10.1136\/heartjnl-2024-325150.","DOI":"10.1136\/heartjnl-2024-325150"},{"key":"3219_CR8","doi-asserted-by":"publisher","unstructured":"Morten K, Shoaib A, B\u00f8rge GN, Per ES, J\u00f8rgen Tobias K, Andreas F, et al. Diabetes and elevated plasma glucose in heart valve calcification and disease: the Copenhagen General Population Study. Eur J Prev Cardiol. 2025;32(17). https:\/\/doi.org\/10.1093\/eurjpc\/zwaf106.","DOI":"10.1093\/eurjpc\/zwaf106"},{"key":"3219_CR9","doi-asserted-by":"publisher","unstructured":"Maoxiang Z, Yang L, Wei H, Guangyuan S, Shouling W. Long-term glycemic exposure, glycemic control stability and incident calcific aortic valve disease: A prospective cohort study. Diabetes Obes Metab. 2025;28(2). https:\/\/doi.org\/10.1111\/dom.70285.","DOI":"10.1111\/dom.70285"},{"key":"3219_CR10","doi-asserted-by":"publisher","unstructured":"Ridhima G, Samantha S, Davide C, Bimmer EC, Usman B, Rishi C, et al. Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry. Int J Cardiol. 2020;322(0). https:\/\/doi.org\/10.1016\/j.ijcard.2020.08.035.","DOI":"10.1016\/j.ijcard.2020.08.035"},{"key":"3219_CR11","doi-asserted-by":"publisher","unstructured":"Xiaoyang S, Naritatsu S, Takeshi M, Tomohiko T, Hiroki S, Kenji A, et al. Long-Term Impact of Diabetes Mellitus on Initially Conservatively Managed Patients With Severe Aortic Stenosis. Circ J. 2020;85(7). https:\/\/doi.org\/10.1253\/circj.CJ-20-0681.","DOI":"10.1253\/circj.CJ-20-0681"},{"key":"3219_CR12","doi-asserted-by":"publisher","unstructured":"Ernesto MN, Miriam GO, Lara M, Mattie G, Laura MA, Adela N, et al. Influence of diabetes mellitus on the pathological profile of aortic stenosis: a sex-based approach. Cardiovasc Diabetol. 2023;22(1). https:\/\/doi.org\/10.1186\/s12933-023-02009-w.","DOI":"10.1186\/s12933-023-02009-w"},{"key":"3219_CR13","doi-asserted-by":"publisher","unstructured":"Augustin C, David M, Sandro N, Nicolas L, Gilles L, Pascal D, et al. Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosis. Heart. 2022;108(22). https:\/\/doi.org\/10.1136\/heartjnl-2022-320897.","DOI":"10.1136\/heartjnl-2022-320897"},{"key":"3219_CR14","doi-asserted-by":"publisher","unstructured":"Daisuke Y, Koichi T, Jun-Ya Y, Ryohei M, Shigeru M, Satoshi K, et al. Diabetes mellitus adversely affects mortality and recurrence after valve surgery for infective endocarditis. J Thorac Cardiovasc Surg. 2017;155(3). https:\/\/doi.org\/10.1016\/j.jtcvs.2017.09.013.","DOI":"10.1016\/j.jtcvs.2017.09.013"},{"key":"3219_CR15","doi-asserted-by":"publisher","unstructured":"Magdalena K, Piotr M, Micha\u0142 Z, Anetta U, Joanna N. Diabetes concomitant to aortic stenosis is associated with increased expression of NF-\u03baB and more pronounced valve calcification. Diabetologia. 2021;64(11). https:\/\/doi.org\/10.1007\/s00125-021-05545-w.","DOI":"10.1007\/s00125-021-05545-w"},{"key":"3219_CR16","doi-asserted-by":"publisher","unstructured":"Laura MA, Nerea CA, Tamara SO, Cecilia CV, Jorge S, Teresa T, et al. Diabetes Mellitus and Its Implications in Aortic Stenosis Patients. Int J Mol Sci. 2021;22(12). https:\/\/doi.org\/10.3390\/ijms22126212.","DOI":"10.3390\/ijms22126212"},{"key":"3219_CR17","doi-asserted-by":"publisher","unstructured":"Friederike Irmgard S, Andreas W, Vera S, Sebastian Johannes B, Moritz Benjamin I, Artur L, et al. Metformin mitigates aortic valve degeneration in an ex vivo three-dimensional tissue model. Sci Rep. 2025;15(1). https:\/\/doi.org\/10.1038\/s41598-025-31070-6.","DOI":"10.1038\/s41598-025-31070-6"},{"key":"3219_CR18","doi-asserted-by":"publisher","unstructured":"Nerea CA, Tamara SO, Luis FLA, Jorge S, Luis RP, Teresa T, et al. Diabetes mellitus and aortic stenosis head to head: toward personalized medicine in patients with both pathologies. Transl Res. 2023;259(0). https:\/\/doi.org\/10.1016\/j.trsl.2023.04.002.","DOI":"10.1016\/j.trsl.2023.04.002"},{"key":"3219_CR19","doi-asserted-by":"publisher","unstructured":"Magdalena K, Micha\u0142 Z, Piotr M, Anetta U, Joanna N. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. Cardiovasc Diabetol. 2020;19(1). https:\/\/doi.org\/10.1186\/s12933-020-01068-7.","DOI":"10.1186\/s12933-020-01068-7"},{"key":"3219_CR20","doi-asserted-by":"publisher","unstructured":"Guorong D, Liyi Z, Chunliang W, Shuang W, Jiacheng X, Jing D, et al. AGEs-RAGE axis causes endothelial-to-mesenchymal transition in early calcific aortic valve disease via TGF-\u03b21 and BMPR2 signaling. Exp Gerontol. 2020;141(0). https:\/\/doi.org\/10.1016\/j.exger.2020.111088.","DOI":"10.1016\/j.exger.2020.111088"},{"key":"3219_CR21","doi-asserted-by":"publisher","unstructured":"Maelle C, Emmanuelle M, Gaultier S, Matteo P, Romain P, Simon L, et al. Myocardial transcriptomic analysis of diabetic patients with aortic stenosis: key role for mitochondrial calcium signaling. Cardiovasc Diabetol. 2024;23(1). https:\/\/doi.org\/10.1186\/s12933-024-02329-5.","DOI":"10.1186\/s12933-024-02329-5"},{"key":"3219_CR22","doi-asserted-by":"publisher","unstructured":"Laura MA, In\u00e9s PS, Germ\u00e1n HF, Gabriel BL, Emilio BL, Roc\u00edo E, et al. The Influence of Diabetes Mellitus and Kidney Dysfunction on Oxidative Stress, a Reflection of the Multisystem Interactions in Aortic Stenosis. Antioxid Basel. 2025;14(7). https:\/\/doi.org\/10.3390\/antiox14070888.","DOI":"10.3390\/antiox14070888"},{"key":"3219_CR23","doi-asserted-by":"publisher","unstructured":"M RC. Oxidative stress associates with advanced glycation end products accumulation and aortic stenosis severity in patients with concomitant type 2 diabetes. J Physiol Pharmacol. 2025;76(4). https:\/\/doi.org\/10.26402\/jpp.2025.4.03.","DOI":"10.26402\/jpp.2025.4.03"},{"key":"3219_CR24","doi-asserted-by":"publisher","unstructured":"Nerea CA, Elena RS, Tamara SO, Elisa MG, Ines PS, Cristina JA, et al. Global Oxidative Status Is Linked to Calcific Aortic Stenosis: The Differences Due to Diabetes Mellitus and the Effects of Metformin. Antioxid Basel. 2023;12(5). https:\/\/doi.org\/10.3390\/antiox12051024.","DOI":"10.3390\/antiox12051024"},{"key":"3219_CR25","doi-asserted-by":"publisher","unstructured":"Anne W, Carl Johan \u00d6, Anna N, David K, Tomas J, Lars L, et al. Aortic valve calcification across stages of dysglycemia in middle-aged individuals from the general population. Cardiovasc Diabetol. 2025;24(1). https:\/\/doi.org\/10.1186\/s12933-025-02634-7.","DOI":"10.1186\/s12933-025-02634-7"},{"key":"3219_CR26","doi-asserted-by":"publisher","unstructured":"Magdalena K, Kamila WU, Jacek T, Sebastian W, Micha\u0142 Z, Joanna N. Dysglycaemia is associated with the pattern of valvular calcification in micro-computed tomography analysis: an observational study in patients with severe aortic stenosis. Cardiovasc Diabetol. 2025;24(1). https:\/\/doi.org\/10.1186\/s12933-025-02691-y.","DOI":"10.1186\/s12933-025-02691-y"},{"key":"3219_CR27","doi-asserted-by":"publisher","unstructured":"Kosuke M, Kazuo O, Toshikazu DT, Makoto K, Jun Y, Keisuke S, et al. Reduced peak pressure gradient in patients with aortic stenosis and type 2 diabetes. Am J Physiol Heart Circ Physiol. 2025;329(1). https:\/\/doi.org\/10.1152\/ajpheart.00255.2025.","DOI":"10.1152\/ajpheart.00255.2025"},{"key":"3219_CR28","doi-asserted-by":"publisher","unstructured":"Jian LY, Abhishek D, Aseel A, Anna-Marie M, Kelly SP, Sarah LA, et al. Cardiovascular MRI Feature-Tracking Strain Rate for Assessment of Diastolic Function. Radiol Cardiothorac Imaging. 2025;7(5). https:\/\/doi.org\/10.1148\/ryct.240447.","DOI":"10.1148\/ryct.240447"},{"key":"3219_CR29","doi-asserted-by":"publisher","unstructured":"Nicholas J, John PG, Richard MC, Oliver JR, Amrit C, Sharmaine T, et al. Association Between Type 2 Diabetes and Changes in Myocardial Structure, Contractile Function, Energetics, and Blood Flow Before and After Aortic Valve Replacement in Patients With Severe Aortic Stenosis. Circulation. 2023;148(15). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.063444.","DOI":"10.1161\/CIRCULATIONAHA.122.063444"},{"key":"3219_CR30","doi-asserted-by":"publisher","unstructured":"Abhishek D, Emer MB, Aseel A, Gaurav SG, Christopher DS, Jian LY, et al. Impact of diabetes on remodelling, microvascular function and exercise capacity in aortic stenosis. Open Heart. 2023;10(2). https:\/\/doi.org\/10.1136\/openhrt-2023-002441.","DOI":"10.1136\/openhrt-2023-002441"},{"key":"3219_CR31","doi-asserted-by":"publisher","unstructured":"Luis RP, Jos\u00e9 MB, Mar\u00eda GB. Coronary flow reserve in degenerative aortic stenosis and diabetes mellitus: An intriguing question. Kardiol Pol. 2023;80(12). https:\/\/doi.org\/10.33963\/KP.a2022.0256.","DOI":"10.33963\/KP.a2022.0256"},{"key":"3219_CR32","doi-asserted-by":"publisher","unstructured":"Artur D, \u0141ukasz R, Dariusz D, Jacek L, Pawe\u0142 K. Impact of diabetes mellitus on the diagnostic performance of fractional flow reserve in patients with severe aortic stenosis. Kardiol Pol. 2022;80(12). https:\/\/doi.org\/10.33963\/KP.a2022.0194.","DOI":"10.33963\/KP.a2022.0194"},{"key":"3219_CR33","doi-asserted-by":"publisher","unstructured":"Yuval A, Amir A, Ibrahim N, Nili S, Sameer K. Glycemic control after aortic valve replacement: A retrospective study. Int J Cardiol Heart Vasc. 2025;56(0). https:\/\/doi.org\/10.1016\/j.ijcha.2024.101596.","DOI":"10.1016\/j.ijcha.2024.101596"},{"key":"3219_CR34","doi-asserted-by":"publisher","unstructured":"Ahston DS, Khalifa B, Soha D, Amin J, Jassim AS, Charbel AK. Diabetes is associated with a higher incidence of short-term mortality risk and readmission in patients who undergo surgical but not transcatheter aortic valve replacement. Open Heart. 2025;12(1). https:\/\/doi.org\/10.1136\/openhrt-2024-003019.","DOI":"10.1136\/openhrt-2024-003019"},{"key":"3219_CR35","doi-asserted-by":"publisher","unstructured":"Sarah K, Soha D, Jassim AS, Hani J, Charbel AK. Trends and Outcomes of Aortic Valve Replacement in Patients With Diabetes in the US. Front Cardiovasc Med. 2022;9(0). https:\/\/doi.org\/10.3389\/fcvm.2022.844068.","DOI":"10.3389\/fcvm.2022.844068"},{"key":"3219_CR36","doi-asserted-by":"publisher","unstructured":"Astrid C, van N, Raquel BS, Roberto Blanco M, Didier T, Fabio S Jr, de Marco B. Diabetes mellitus in transfemoral transcatheter aortic valve implantation: a propensity matched analysis. Cardiovasc Diabetol. 2022;21(1). https:\/\/doi.org\/10.1186\/s12933-022-01654-x.","DOI":"10.1186\/s12933-022-01654-x"},{"key":"3219_CR37","doi-asserted-by":"publisher","unstructured":"Murat Can G, Engin B. Transcatheter Aortic Valve Implantation in Nonagenarians: A Comparative Analysis of Baseline Characteristics and 1-Year Outcomes. J Cardiovasc Dev Dis. 2025;12(9). https:\/\/doi.org\/10.3390\/jcdd12090327.","DOI":"10.3390\/jcdd12090327"},{"key":"3219_CR38","doi-asserted-by":"publisher","unstructured":"Wen S, Shi T, Yiyuan H, Xinqun H, Shenghua Z, Zhenfei F. Clinical characteristics of severe aortic stenosis patients combined with diabetes mellitus after transcatheter aortic valve replacement and short-term outcome. Zhong Nan Xue Xue Bao Yi Xue Ban. 2022;47(3). https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2022.210357.","DOI":"10.11817\/j.issn.1672-7347.2022.210357"},{"key":"3219_CR39","doi-asserted-by":"publisher","unstructured":"Shingo M, Yohei O, Junichi M, Yuji I, Norio T, Toru N, et al. Impact of diabetes mellitus on outcome after transcatheter aortic valve replacement: Identifying high-risk diabetic population from the OCEAN-TAVI registry. Catheter Cardiovasc Interv. 2021;98(7). https:\/\/doi.org\/10.1002\/ccd.29960.","DOI":"10.1002\/ccd.29960"},{"issue":"6","key":"3219_CR40","doi-asserted-by":"publisher","first-page":"e16056","DOI":"10.7759\/cureus.16056","volume":"13","author":"J Malik","year":"2021","unstructured":"Malik J, Patel JR, Joundi H, Pereira KN, Pannu AK, Haneef G, et al. Incidence and Predictors of In-Hospital Mortality Among Diabetics Undergoing Transcatheter Aortic Valve Replacement. Cureus. 2021;13(6):e16056. https:\/\/doi.org\/10.7759\/cureus.16056 . PubMed PMID: 34336528; PubMed Central PMCID: PMC8321421.","journal-title":"Cureus"},{"key":"3219_CR41","doi-asserted-by":"publisher","unstructured":"H\u00fcseyin A, Murat Can G, Telat K, Engin B. Outcomes of Transcatheter Aortic Valve Implantation in Patients with and without Diabetes Mellitus. Braz J Cardiovasc Surg. 2024;39(4). https:\/\/doi.org\/10.21470\/1678-9741-2023-0088.","DOI":"10.21470\/1678-9741-2023-0088"},{"key":"3219_CR42","doi-asserted-by":"publisher","unstructured":"Qingyun Y, Qingan F, Xiaowei M, Huijian W, Yunlei X, Yue C, et al. Impact of glycemic control metrics on short- and long-term mortality in transcatheter aortic valve replacement patients: a retrospective cohort study from the MIMIC-IV database. Cardiovasc Diabetol. 2025;24(1). https:\/\/doi.org\/10.1186\/s12933-025-02684-x.","DOI":"10.1186\/s12933-025-02684-x"},{"key":"3219_CR43","doi-asserted-by":"publisher","unstructured":"Xiangming H, Dejing F, Yuxuan Z, Can W, Yang C, Guannan N, et al. Prognostic effect of stress hyperglycemia ratio on patients with severe aortic stenosis receiving transcatheter aortic valve replacement: a prospective cohort study. Cardiovasc Diabetol. 2024;23(1). https:\/\/doi.org\/10.1186\/s12933-024-02160-y.","DOI":"10.1186\/s12933-024-02160-y"},{"key":"3219_CR44","doi-asserted-by":"publisher","unstructured":"Azam S, Mahsa M, Saeide B, Atefeh A, Zahra TJ. Investigating the results of transcatheter aortic valve implantation (TAVI) in non-diabetic and diabetic patients: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2025;25(1). https:\/\/doi.org\/10.1186\/s12872-025-04646-3.","DOI":"10.1186\/s12872-025-04646-3"},{"key":"3219_CR45","doi-asserted-by":"publisher","unstructured":"Roberta Andreucci Pereira G, Ricardo Fonseca Oliveira SM, Evandro Martins F, Lidia C, Karlos Daniell Ara\u00fajo DS, Jo\u00e3o, Androlage V et al. A,. Effect of Diabetes Mellitus on Clinical Outcomes After Transcatheter Aortic Valve Implantation: An Updated Systematic Review and Meta-Analysis. Catheter Cardiovasc Interv. 2025;106(7). https:\/\/doi.org\/10.1002\/ccd.70190","DOI":"10.1002\/ccd.70190"},{"key":"3219_CR46","doi-asserted-by":"publisher","first-page":"110050","DOI":"10.1016\/j.diabres.2022.110050","volume":"191","author":"TY Ko","year":"2022","unstructured":"Ko TY, Lin TT, Hsu JC, Yang YY, Chuang SL, Lin LY, et al. Incidence, risk factors and predictors of cardiovascular mortality for aortic stenosis among patients with diabetes mellitus. Diabetes Res Clin Pract. 2022;191:110050. https:\/\/doi.org\/10.1016\/j.diabres.2022.110050.","journal-title":"Diabetes Res Clin Pract"},{"key":"3219_CR47","doi-asserted-by":"publisher","unstructured":"Ileana M, Dan S, Agneta S, Maya S. Aortic valve disease in diabetes: Molecular mechanisms and novel therapies. J Cell Mol Med. 2021;25(20). https:\/\/doi.org\/10.1111\/jcmm.16937.","DOI":"10.1111\/jcmm.16937"},{"key":"3219_CR48","doi-asserted-by":"publisher","unstructured":"Aleksander D, Michel Pompeu S, Serge S, Basel R, Gianluca T, Massimo B, Commentary. Osteogenic Metaplasia of the Aortic Valve. Do Bacteria, Diabetes, and Dyslipidemia Play a Role? Semin Thorac Cardiovasc Surg. 2021;34(4). https:\/\/doi.org\/10.1053\/j.semtcvs.2021.11.002.","DOI":"10.1053\/j.semtcvs.2021.11.002"},{"key":"3219_CR49","doi-asserted-by":"publisher","unstructured":"Ta-Yu Y, Aeron MS, Line D, Gina MP, Pradeep N, James CE, et al. Plasma Proteomic Biomarkers of Aortic Stenosis: A Mendelian Randomization Study. J Am Coll Cardiol. 2024;84(6). https:\/\/doi.org\/10.1016\/j.jacc.2024.05.046.","DOI":"10.1016\/j.jacc.2024.05.046"},{"key":"3219_CR50","doi-asserted-by":"publisher","unstructured":"Yujia C, Feng X, Ruxing W. Calcified aortic valve disease complicated with and without diabetes mellitus: the underlying pathogenesis. Rev Cardiovasc Med. 2022;23(1). https:\/\/doi.org\/10.31083\/j.rcm2301007.","DOI":"10.31083\/j.rcm2301007"},{"key":"3219_CR51","doi-asserted-by":"publisher","unstructured":"Joanna N. Diabetes mellitus as a risk factor for aortic stenosis: from new mechanisms to clinical implications. Kardiol Pol. 2021;79(10). https:\/\/doi.org\/10.33963\/KP.a2021.0137.","DOI":"10.33963\/KP.a2021.0137"},{"key":"3219_CR52","doi-asserted-by":"publisher","unstructured":"Shintaro K, Yukiharu S, Sophia G, Robin D, Jessica Isabel S, Mareike B, et al. PPAR-Gamma Activation May Inhibit the In Vivo Degeneration of Bioprosthetic Aortic and Aortic Valve Grafts under Diabetic Conditions. Int J Mol Sci. 2021;22(20). https:\/\/doi.org\/10.3390\/ijms222011081.","DOI":"10.3390\/ijms222011081"},{"key":"3219_CR53","doi-asserted-by":"publisher","unstructured":"Jessica IS, Joana B, Naima N, Margriet D, Karlheinz O, Patrick P. Crosstalk of Diabetic Conditions with Static Versus Dynamic Flow Environment-Impact on Aortic Valve Remodeling. Int J Mol Sci. 2021;22(13). https:\/\/doi.org\/10.3390\/ijms22136976.","DOI":"10.3390\/ijms22136976"},{"key":"3219_CR54","doi-asserted-by":"publisher","unstructured":"Arsenii Z, Daria E, John-Peder Escobar K, Mari-Liis K, K\u00e5re-Olav S, Jarle V. Hyperglycemia-simulating environment attenuated experimentally induced calcification in cultured human aortic valve interstitial cells. Scand Cardiovasc J. 2024;58(1). https:\/\/doi.org\/10.1080\/14017431.2024.2353070.","DOI":"10.1080\/14017431.2024.2353070"},{"issue":"5","key":"3219_CR55","doi-asserted-by":"publisher","first-page":"e14167","DOI":"10.1111\/eci.14167","volume":"54","author":"JW Bellinge","year":"2024","unstructured":"Bellinge JW, Chan DC, Pang J, Francis RJ, Page MM, Watts GF, et al. Plasma lipoprotein(a) is associated with calcification activity of the thoracic aorta and aortic valve in statin na\u00efve individuals with diabetes mellitus. Eur J Clin Invest. 2024;54(5):e14167. https:\/\/doi.org\/10.1111\/eci.14167 . PubMed PMID: 38265272.","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"3219_CR56","doi-asserted-by":"publisher","first-page":"276","DOI":"10.31083\/j.rcm2508276","volume":"25","author":"J He","year":"2024","unstructured":"He J, Xiong Z, Christopher O, Huang Z, Xu C, Liu M, et al. Low-Density Lipoprotein Cholesterol, Type 2 Diabetes and Progression of Aortic Stenosis: The RED-CARPET Heart Valve Subgroup Cohort Study. Rev Cardiovasc Med. 2024;25(8):276. https:\/\/doi.org\/10.31083\/j.rcm2508276 . PubMed PMID: 39228497; PubMed Central PMCID: PMC11366981.","journal-title":"Rev Cardiovasc Med"},{"key":"3219_CR57","doi-asserted-by":"publisher","unstructured":"Melissa H, Marcel S, Andrea K, Muchtiar K, Andreas M, Wolfgang ES, et al. Diabetes mellitus aggravates myocardial inflammation and oxidative stress in aortic stenosis: a mechanistic link to HFpEF features. Cardiovasc Diabetol. 2025;24(1). https:\/\/doi.org\/10.1186\/s12933-025-02748-y.","DOI":"10.1186\/s12933-025-02748-y"},{"key":"3219_CR58","doi-asserted-by":"publisher","unstructured":"Sandra SE, Mercedes CP, Alberto CC, Paula R, Mar\u00eda DM, Luc\u00eda BM, et al. Integrin-Linked Kinase Expression in Human Valve Endothelial Cells Plays a Protective Role in Calcific Aortic Valve Disease. Antioxid Basel. 2022;11(9). https:\/\/doi.org\/10.3390\/antiox11091736.","DOI":"10.3390\/antiox11091736"},{"key":"3219_CR59","doi-asserted-by":"publisher","unstructured":"Maria DM, Sandra SE, Alberto CC, Sara JO, Carlos Z, Marta S. Indoxyl Sulfate-Induced Valve Endothelial Cell Endothelial-to-Mesenchymal Transition and Calcification in an Integrin-Linked Kinase-Dependent Manner. Cells. 2024;13(6). https:\/\/doi.org\/10.3390\/cells13060481.","DOI":"10.3390\/cells13060481"},{"key":"3219_CR60","doi-asserted-by":"publisher","unstructured":"Li S, Zhen Y, Fei L, Zhejun C. Oxidative stress and valvular endothelial cells in aortic valve calcification. Biomed Pharmacother. 2023;163(0). https:\/\/doi.org\/10.1016\/j.biopha.2023.114775.","DOI":"10.1016\/j.biopha.2023.114775"},{"key":"3219_CR61","doi-asserted-by":"publisher","unstructured":"Nalin HD, Sara B, Karlheinz P. Uncoupling the Vicious Cycle of Mechanical Stress and Inflammation in Calcific Aortic Valve Disease. Front Cardiovasc Med. 2022;9(0). https:\/\/doi.org\/10.3389\/fcvm.2022.783543.","DOI":"10.3389\/fcvm.2022.783543"},{"key":"3219_CR62","doi-asserted-by":"publisher","unstructured":"Chao S, Tumin S, Chaoliang L, Jianqiang L. Calcific aortic valve disease: can targeting endothelial-mesenchymal transition be a new alternative to surgery?-a narrative review. Cardiovasc Diagn Ther. 2026;16(1). https:\/\/doi.org\/10.21037\/cdt-2025-373.","DOI":"10.21037\/cdt-2025-373"},{"key":"3219_CR63","doi-asserted-by":"publisher","unstructured":"Mark CB, Simon K, Thomas FL, Elena A. Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis. Circ Res. 2021;128(9). https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317979.","DOI":"10.1161\/CIRCRESAHA.120.317979"},{"issue":"3","key":"3219_CR64","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1631\/jzus.B","volume":"22","author":"J Fan","year":"2021","unstructured":"Fan J, Yu C, Ren K, Lin W, Ng S, Chen Z, et al. Kidney function change after transcatheter aortic valve replacement in patients with diabetes and\/or hypertension. J Zhejiang Univ Sci B. 2021;22(3):241\u20137. https:\/\/doi.org\/10.1631\/jzus.B. 2000431 PubMed PMID: 33719229; PubMed Central PMCID: PMC7982332.","journal-title":"J Zhejiang Univ Sci B"},{"key":"3219_CR65","doi-asserted-by":"publisher","unstructured":"Miriam GO, Mattie GZ, Susana SIG, Amaya FC, Paula C, Adela N, et al. Chemerin is a new sex-specific target in aortic stenosis concomitant with diabetes regulated by the aldosterone\/mineralocorticoid receptor axis. Am J Physiol Heart Circ Physiol. 2025;328(3). https:\/\/doi.org\/10.1152\/ajpheart.00763.2024.","DOI":"10.1152\/ajpheart.00763.2024"},{"key":"3219_CR66","doi-asserted-by":"publisher","unstructured":"Quangong Z, Boyao Z, Xiaoxian W, Jingwen Z, Xiangyang X, Yang Y, et al. Canagliflozin Delays Aortic Valve Calcification by Enhancing the AMPK\/Nrf2\/HO-1 Antioxidant Signaling Pathway in Valvular Interstitial Cells. FASEB J. 2025;39(10). https:\/\/doi.org\/10.1096\/fj.202403109R.","DOI":"10.1096\/fj.202403109R"},{"key":"3219_CR67","doi-asserted-by":"publisher","unstructured":"Pasquale P, Marta B, Emanuele G, Roberto S, Luca B, Leonardo P, et al. SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI). Cardiovasc Diabetol. 2024;23(1). https:\/\/doi.org\/10.1186\/s12933-024-02504-8.","DOI":"10.1186\/s12933-024-02504-8"},{"key":"3219_CR68","doi-asserted-by":"publisher","unstructured":"Ignacio JAS, Juan PSL, Emad AA, Mar\u00eda MV, Ignacio CG, Luis NF, et al. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial. Eur J Heart Fail. 2021;24(3). https:\/\/doi.org\/10.1002\/ejhf.2370.","DOI":"10.1002\/ejhf.2370"},{"key":"3219_CR69","doi-asserted-by":"publisher","unstructured":"Pasquale P, Marta B, Emanuele G, Roberto S, Luca B, Leonardo P, et al. Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI). Cardiovasc Diabetol. 2025;24(1). https:\/\/doi.org\/10.1186\/s12933-025-02773-x.","DOI":"10.1186\/s12933-025-02773-x"},{"key":"3219_CR70","doi-asserted-by":"publisher","unstructured":"Feng L, Haipeng C. Diabetes and calcific aortic valve disease: controversy of clinical outcomes in diabetes after aortic valve replacement. Front Endocrinol Lausanne. 2025;16(0). https:\/\/doi.org\/10.3389\/fendo.2025.1577762.","DOI":"10.3389\/fendo.2025.1577762"},{"key":"3219_CR71","doi-asserted-by":"publisher","unstructured":"Hiroshi I, Yoshiharu E, Shohei T, Kazuhiro A, Hiroki N, Kenji Y, et al. Analysis of predictors of fever after aortic valve replacement: Diabetic patients are less likely to develop fever after aortic valve replacement, a single-centre retrospective study. J Perioper Pr. 2024;35(5). https:\/\/doi.org\/10.1177\/17504589241232503.","DOI":"10.1177\/17504589241232503"},{"key":"3219_CR72","doi-asserted-by":"publisher","unstructured":"Mi Z, Xiaohong L, Xiwu Z, Zhigang S, Lin H, Yuanyuan H, et al. MicroRNA-30b is a multifunctional regulator of aortic valve interstitial cells. J Thorac Cardiovasc Surg. 2013;147(3). https:\/\/doi.org\/10.1016\/j.jtcvs.2013.05.011.","DOI":"10.1016\/j.jtcvs.2013.05.011"},{"key":"3219_CR73","doi-asserted-by":"publisher","unstructured":"Rui S, Yufeng Z, Lihua A, David AF, Xianzhong M. MicroRNA-204 Deficiency in Human Aortic Valves Elevates Valvular Osteogenic Activity. Int J Mol Sci. 2019;21(1). https:\/\/doi.org\/10.3390\/ijms21010076.","DOI":"10.3390\/ijms21010076"},{"key":"3219_CR74","doi-asserted-by":"publisher","unstructured":"Rongjian X, Min Z, Yun Y, Zhuo H, Chunying S, Xianglin H, et al. MicroRNA-449c-5p inhibits osteogenic differentiation of human VICs through Smad4-mediated pathway. Sci Rep. 2017;7(1). https:\/\/doi.org\/10.1038\/s41598-017-09390-z.","DOI":"10.1038\/s41598-017-09390-z"},{"key":"3219_CR75","doi-asserted-by":"publisher","unstructured":"Alberto CC, Silvia M, Maria DM, Blanca FR, Carlos Z, Marta S. Integrated biomarker landscape for the early detection and management of calcific aortic valve disease. Eur J Clin Invest. 2025;56(1). https:\/\/doi.org\/10.1111\/eci.70147.","DOI":"10.1111\/eci.70147"},{"key":"3219_CR76","doi-asserted-by":"publisher","unstructured":"Alberto CC, Maria DM, Blanca FR, Carlos Z, Marta S. Extracellular Vesicles in Calcific Aortic Valve Disease: From Biomarkers to Drug Delivery Applications. Biomolecules. 2025;15(11). https:\/\/doi.org\/10.3390\/biom15111548.","DOI":"10.3390\/biom15111548"},{"key":"3219_CR77","doi-asserted-by":"publisher","unstructured":"Maija S, Raimo J, Jagadish V, Annamaria L, Mika AK, Teemu K, et al. Biomarkers reflecting insulin resistance increase the risk of aortic stenosis in a population-based study of 10,144 Finnish men. Ann Med. 2024;56(1). https:\/\/doi.org\/10.1080\/07853890.2024.2419996.","DOI":"10.1080\/07853890.2024.2419996"},{"key":"3219_CR78","doi-asserted-by":"publisher","unstructured":"Anna OW, Tomasz U, Pawe\u0142 G, Jan M, Szymon P, Beata K, et al. Lysophosphatidylcholine as a biomarker for severe aortic stenosis in diabetic patients: Preliminary report. Kardiol Pol. 2025;83(10). https:\/\/doi.org\/10.33963\/v.phj.106620.","DOI":"10.33963\/v.phj.106620"},{"key":"3219_CR79","doi-asserted-by":"publisher","unstructured":"In-Chang H, Seok K, Dachung B, Changhyun P, Sooyoung Y, Yeonyee EY, et al. Impact of glycemic control on the progression of aortic stenosis: a single-center cohort study using a common data model. BMC Endocr Disord. 2023;23(1). https:\/\/doi.org\/10.1186\/s12902-023-01403-5.","DOI":"10.1186\/s12902-023-01403-5"},{"key":"3219_CR80","doi-asserted-by":"publisher","unstructured":"Qiang S, Lin F, Chen J, Dingyi Y, Xingyu Q, Fuqiang T, et al. Identification and validation of the diagnostic biomarker MFAP5 for CAVD with type 2 diabetes by bioinformatics analysis. Front Immunol. 2025;15(0). https:\/\/doi.org\/10.3389\/fimmu.2024.1506663.","DOI":"10.3389\/fimmu.2024.1506663"},{"key":"3219_CR81","doi-asserted-by":"publisher","unstructured":"Avinash BK, Padraic C, Yuzhen D, Anders I, Stefan J, Agneta S, et al. Plasma-Derived Extracellular Vesicle-Propagated microRNA From Aortic Stenosis Patients Render Pro-Calcifying Effects on Valve Interstitial Cells. JACC Basic Transl Sci. 2025;10(9). https:\/\/doi.org\/10.1016\/j.jacbts.2025.101327.","DOI":"10.1016\/j.jacbts.2025.101327"},{"key":"3219_CR82","doi-asserted-by":"publisher","unstructured":"Kai-Chun C, Li-Ting H, Kuan-Chih H, Jung-Chi H, David Te-Wei K, Ting-Tse L, et al. Effect of body mass index on mortality for diabetic patients with aortic stenosis. Aging. 2024;16(14). https:\/\/doi.org\/10.18632\/aging.206018.","DOI":"10.18632\/aging.206018"},{"key":"3219_CR83","doi-asserted-by":"publisher","unstructured":"Weibin Y, Li L, Jianfeng Z. Association of Cardiac Valve Calcification and 1-year Mortality after Lower-extremity Amputation in Diabetic Patients: A Retrospective Study. Curr Neurovasc Res. 2023;20(5). https:\/\/doi.org\/10.2174\/0115672026277348231130112221.","DOI":"10.2174\/0115672026277348231130112221"},{"key":"3219_CR84","doi-asserted-by":"publisher","unstructured":"Araz R, Naveed S, Darren KM, Oskar W, Ulf S, Jan B, et al. Left-Sided Degenerative Valvular Heart Disease in Type 1 and Type 2 Diabetes. Circulation. 2022;146(5). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.058072.","DOI":"10.1161\/CIRCULATIONAHA.121.058072"},{"key":"3219_CR85","doi-asserted-by":"publisher","unstructured":"Can GT, Felix N, Clemens E, Leon S, Berit Z, Michael G, et al. Different calcification patterns of tricuspid and bicuspid aortic valves and their clinical impact. Interact Cardiovasc Thorac Surg. 2022;35(6). https:\/\/doi.org\/10.1093\/icvts\/ivac274.","DOI":"10.1093\/icvts\/ivac274"},{"key":"3219_CR86","doi-asserted-by":"publisher","unstructured":"Navneet N, Nupoor N, Edgar A. The Thickened Valve. JACC Case Rep. 2021;2(12). https:\/\/doi.org\/10.1016\/j.jaccas.2020.09.010.","DOI":"10.1016\/j.jaccas.2020.09.010"},{"key":"3219_CR87","doi-asserted-by":"publisher","unstructured":"Xiang Z, Jiahui W, Qian H, Bangyu G, Mengjie H, Xiaobo Y, et al. Integrating bioinformatics and machine learning analyses to identify immune-related secretory proteins and therapeutic small-molecule drugs in calcific aortic valve disease with type 2 diabetes. Front Immunol. 2025;16(0). https:\/\/doi.org\/10.3389\/fimmu.2025.1634655.","DOI":"10.3389\/fimmu.2025.1634655"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03219-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03219-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03219-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:23:12Z","timestamp":1784672592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03219-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3219"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03219-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"206"}}